Global Whole Slide Imaging Market 2023-2030

Description

List of Tables

Global Whole Slide Imaging Market Size, Share & Trends Analysis Report by Technology (Scanners, IT Infrastructure, and ViewerImage Management System), by Application (Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), and by End-User (Academic Institute, Hospitals and Healthcare Institutions, Pharmaceutical Research and Contract Research Organizations (CROs), and Others), Forecast Period (2023-2030)

The global whole slide imaging market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The market's growth is attributed to the increased computer processing power across the globe. The development of powerful computers has made it possible to process and analyze enormous images generated by WSI scanners. Image analysis has grown more rapid and precise as a result of technology. According to the National Institute of Health (gov.), in July 2023, the use of whole slide imaging has increased among pathologists, pathology departments, and research scientists. A survey conducted in 2018 and 2020 found that the comfort of pathologists to make a primary diagnosis with or without access to traditional glass slides increased from 54% to 90%, and from 23% to 60%, respectively. This is largely attributed to advancements in technology, including state-of-the-art optics and robotics, increased computer processing power, data transfer speeds, software development, and cloud storage solutions. As such, WSI has been used for telepathology, consultation, tumor boards, archiving slides, and comparisons with multiple immunohistochemical staining.

Segmental Outlook

The global whole slide imaging market is segmented on the technology, application, and end-user. Based on the technology, the market is sub-segmented into scanners, it infrastructure, and viewer image management system. Based on the application, the market is sub-segmented into telepathology, cytopathology, immunohistochemistry, hematopathology, and others. Furthermore, on the basis of end-user, the market is sub-segmented into academic institute, hospitals and healthcare institutions, pharmaceutical research and contract research organizations (CROs), and others. The cytopathology subcategory is expected to capture a significant portion of the market share within the application segment. The increasing population base prone to numerous diseases. Cytopathology is a specialized diagnostic procedure that examines individual cells removed from tissues to determine the source and nature of a disease.

The Scanners Sub-Segment is Anticipated to Hold a Considerable Share of the Global Whole Slide Imaging Market

Among the technology, the scanners sub-segment is expected to hold a considerable share of the global whole slide imaging market. The segmental growth is attributed to the increased demand for digital pathology across the globe. Increase in demand for digital pathology solutions remote access to slides, telepathology, and collaborative analysis are merely a few of the advantages of digital pathology. Pathologists and researchers can benefit from digital pathology by utilizing scanners such as the NanoZoomer S20MD. For instance, in March 2023, Hamamatsu Photonics, released the new NanoZoomer S20MD Slide scanner system (C16300-21MDEU).The NanoZoomer S20MD Slide scanner system offers excellent image quality and rapid throughput, scanning 20 slides in 15 minutes. It is designed with the same pixel pathway as the high-end model and includes image acquisition and viewing software. It is additionally compliant with IVDR (EU), UKCA (UK) and IvDO (CH) regulations.

Regional Outlook

The global whole slide imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to rising awareness of the benefits of whole slide imaging, in addition to an extensive population base in some countries such as India and China, have contributed to the region's market growth.

The North America Region is Expected to Grow at a Significant CAGR in the Global Whole Slide Imaging Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the telepathology and tele-cytology development across the globe. The study's success in reaching high sensitivity and specificity rates in remote cytological evaluations emphasizes the significance of telepathology in healthcare improvement. Telepathology, that involve tele-cytology, enables pathologists to remotely access and interpret digital slides, making it easier to provide diagnosis and consultations, particularly in areas where specialist expertise is scarce. According to the MDPI, in October 2023, the prospective study analyzed 314 Rapid Remote Online Cytological Evaluations (154 imprint cytologies, 143 fine needle aspirations and 17 brush cytologies) performed on 239 patients at the LungenClinic Grosshansdorf. During on-site evaluation via tele-cytology, the time requirement was recorded and the findings were compared with the cyto-/histological and final diagnoses. The results showed that 86 cytological benign, 190 malignant and 38 unclear diagnoses were recorded. Excluding the 37 specimens with unclear diagnoses, the sensitivity rate was 90.5%, the specificity rate was 98.5% and the correct classification rate was 92.4% with regard to the final diagnosis. The sensitivity rate for the cytological detection of malignant tumors was 76.1% for fine-needle aspirations and 92.5% when excluding the 37 specimens with unclear findings.

Market Players Outlook

The major companies serving the whole slide imaging market include Leica Microsystems GmbH, Olympus Corp. Philips International B.V., NIKON CORP., Visiopharm A/S, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Infinitt collaborated with Hamamatsu, offered improved integration with NanoZoomers, allowing laboratories and pathologists to review slides in an end-to-end operational workflow. Furthermore, the integration of IDPS with LIS will allow pathologists to work more efficiently in a digital environment.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global whole slide imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027993

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. 3DHISTECH Ltd.
- 1.1.1. Overview
- 1.1.2. Financial Analysis
- 1.1.3. SWOT Analysis
- 1.1.4. Recent Developments
3.3. Aiforia Technologies Oyj
- 1.1.5. Overview
- 1.1.6. Financial Analysis
- 1.1.7. SWOT Analysis
- 1.1.8. Recent Developments
3.4. Akoya Biosciences, Inc.
- 1.1.9. Overview
- 1.1.10. Financial Analysis
- 1.1.11. SWOT Analysis
- 1.1.12. Recent Developments
1.2. Key Strategy Analysis

2. Market Segmentation

2.1. Global Whole Slide Imaging Market by Technology
- 2.1.1. Scanners
- 2.1.2. IT Infrastructure
- 2.1.3. ViewerImage Management System
2.2. Global Whole Slide Imaging Market by Application
- 2.2.1. Telepathology
- 2.2.2. Cytopathology
- 2.2.3. Immunohistochemistry
- 2.2.4. Hematopathology
- 2.2.5. Others(Neuropathology, and Forensic Pathology)
2.3. Global Whole Slide Imaging Market by End User
- 2.3.1. Brushed Micromotor
- 2.3.2. Brushless Micromotor
2.4. Global Whole Slide Imaging Market by End-User
- 2.4.1. Academic Institute
- 2.4.2. Hospitals and Healthcare Institutions
- 2.4.3. Pharmaceutical Research and Contract Research Organizations (CROs)
- 2.4.4. Others(Biotechnology and Pharmaceutical Companies, and Government Health Agencies)

3. Regional Analysis

3.1. North America
- 3.1.1. United States
- 3.1.2. Canada
3.2. Europe
- 3.2.1. UK
- 3.2.2. Germany
- 3.2.3. Italy
- 3.2.4. Spain
- 3.2.5. France
- 3.2.6. Rest of Europe
3.3. Asia-Pacific
- 3.3.1. China
- 3.3.2. India
- 3.3.3. Japan
- 3.3.4. South Korea
- 3.3.5. Rest of Asia-Pacific
3.4. Rest of the World

4. Company Profiles

4.1. CureMetrix, Inc.
4.2. Flagship Biosciences, Inc.
4.3. HAMAMATSU Group
4.4. Huron Digital Pathology
4.5. Indica Labs, Inc.
4.6. Leica Microsystems GmbH
4.7. MBF Bioscience
4.8. Mikroscan Technologies
4.9. Molecular Machines & Industries GmbH
4.10. NIKON CORP.
4.11. Olympus Corp.
4.12. OPAL KELLY INC.
4.13. OptraSCAN Inc.
4.14. PerkinElmer AES
4.15. Philips International B.V.
4.16. Visiopharm A/S
4.17. Zeiss AG